20 abril 2015
Extending the dose of natalizumab from four weeks up to eight weeks was shown to be well-tolerated and effective in patients, and resulted in no cases of the potentially fatal side effect progressive multifocal leukoencephalopathy, researchers report.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/q5sctZaDgZo/150420144407.htm
